Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of desloratadine 5 mg film-coated tablets vs AERIUS in healthy Thai volunteers under fasting conditions
TCTR20220315005Phase 1Not yet recruiting
- Sponsor
- Polipharm
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Polipharm. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20220315005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220315005.